You are here

Novavax reports promising early trial results of Covid-19 vaccine

nz_novavax_050830.jpg
US biotech company Novavax on Tuesday announced its experimental Covid-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial.

[WASHINGTON] US biotech company Novavax on Tuesday announced its experimental Covid-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial.

The company was given US$...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes